Status:
RECRUITING
Hamburg TranscathEteR Mitral Valve REplacement RegiStry
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Mitral Valve Disease
Eligibility:
All Genders
18-110 years
Brief Summary
The Hamburg TranscathEteR Mitral Valve REplacement RegiStry (HERMES) is a prospective clinical cohort registry aiming to gather follow-up information on short- and long-term outcome of patients with m...
Detailed Description
Mitral valve regurgitation (MR) emerges as the most frequent valvular heart disease in developed coun-tries with prevalence increasing with age. Mitral valve repair is the gold standard therapeutic st...
Eligibility Criteria
Inclusion
- Ability to provide written informed consent in accordance with Good Epidemiological Practice and local legislation.
- Individuals over the age of 18 years.
- Patients with clinically relevant mitral valve disease, who undergo screening for TMVR.
Exclusion
- Insufficient knowledge of the German language, to understand study documents and interview without translation
- Physical or psychological incapability to cooperate in the investigation
Key Trial Info
Start Date :
March 8 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04914468
Start Date
March 8 2021
End Date
December 31 2030
Last Update
June 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Heart and Vascular Center Hamburg
Hamburg, Germany, 20246